Ratio below LLN
An FEV₁/FVC z-score below −1.645 indicates an obstructive ventilatory pattern. The test does not identify the cause by itself.
Race-neutral pulmonary function tool
Calculate race-neutral GLI Global predicted FEV₁, FVC, FEV₁/FVC, lower limits of normal, percent predicted, and z-scores—then review a carefully bounded spirometric pattern and optional bronchodilator response.
Educational clinical decision support. Enter only results from an acceptable, repeatable spirometry session. This tool does not assess maneuver quality, diagnose a disease, or replace the complete PFT report and clinician interpretation.
Race-neutral GLI Global 2022
Step 1
Step 2
Enter both values to apply the current ERS/ATS response threshold.
Results
Enter values, then interpret
PulmTools will calculate race-neutral predicted values, lower limits of normal, percent predicted, z-scores, a bounded spirometric pattern, and optional bronchodilator response.
Interpretive sequence
The ratio is assessed first. FVC then adds context, but lung volumes remain necessary whenever restriction is suspected or obstruction coexists with a low FVC.
An FEV₁/FVC z-score below −1.645 indicates an obstructive ventilatory pattern. The test does not identify the cause by itself.
This suggests possible restriction. Confirm only when TLC is below its lower limit of normal.
This may represent obstruction with air trapping or a mixed ventilatory defect. TLC separates those possibilities.
This is spirometry within the expected range. It does not exclude asthma, early disease, diffusion impairment, or exercise-related physiology.
Beyond 80% predicted
Healthy between-person variability changes with age and differs across spirometric indices. A fixed 80%-predicted cutoff ignores that variation. GLI uses the LMS method to calculate an age-specific distribution, allowing the fifth percentile—z = −1.645—to serve as the lower limit of normal.
| FEV₁ z-score | Magnitude of impairment | How to use it |
|---|---|---|
| ≥ −1.645 | Within expected range | Interpret with the ratio, FVC, quality, and clinical context |
| −1.65 to −2.5 | Mild impairment | Describes functional impairment, not disease severity |
| −2.51 to −4.0 | Moderate impairment | Use the same z-score framework across ages |
| < −4.0 | Severe impairment | Consider complete physiology and the patient’s trajectory |
Current ERS/ATS method
A change greater than 10% of predicted in FEV₁ or FVC meets the current technical-standard threshold. PulmTools displays the absolute change as additional context but does not apply the superseded 12%-and-200-mL rule as its primary result.
A positive response can occur in more than one condition, and its absence does not exclude treatment benefit or asthma. Review medication withholding, timing, maneuver quality, symptoms, and longitudinal results.
Continue to asthma control assessmentFrequently asked questions
A z-score describes how far a measured value is from the age-, height-, and sex-specific reference mean in standard-deviation units after accounting for the shape and variability of the reference distribution. It is more physiologically consistent across age than a fixed percent-predicted cutoff.
The ERS/ATS framework generally places the lower limit of normal at z = −1.645, corresponding to the fifth percentile of the reference distribution. A result near any threshold should be interpreted with measurement uncertainty and clinical context.
No. A fixed 80%-predicted rule does not account for age-dependent variability and can misclassify results. PulmTools displays percent predicted for familiarity but uses the GLI lower limit of normal and z-score for its bounded pattern statement.
No. A preserved FEV₁/FVC ratio with a low FVC suggests possible restriction, but restriction is confirmed when total lung capacity is below its lower limit of normal. A low FVC can also occur with air trapping, submaximal inspiration, or other technical and clinical factors.
The 2021 ERS/ATS interpretive standard defines a positive response as a change greater than 10% of the predicted value in FEV₁ or FVC. This replaced the older 12%-and-200-mL-from-baseline convention in the current technical standard.
It implements the race-neutral GLI Global equation. The 2023 official ATS statement, endorsed by ERS, recommends moving away from race- and ethnicity-specific equations in PFT laboratories and clinical practice.
No. Spirometry can be normal between episodes of asthma and does not assess every pulmonary process. Symptoms, test quality, treatment status, lung volumes, gas transfer, bronchoprovocation, exercise testing, imaging, and longitudinal change may be relevant.
Evidence base
Equation resources and standards reviewed August 16, 2026. PulmTools implements the 2022 GLI Global race-neutral reference equation across its published 3–95-year age range and the 2021 ERS/ATS interpretation framework.
Spirometry is one part of pulmonary physiology. Symptoms, exposure history, imaging, oxygenation, lung volumes, diffusion capacity, exercise response, and serial change may alter clinical interpretation. For tobacco exposure and screening context, use the pack-year and LDCT eligibility calculator.
PulmTools pulmonology cluster
Move between COPD multidimensional assessment, pulmonary-function interpretation, screening eligibility, nodule pathways, malignancy-risk estimation, and pleural-fluid classification without leaving the Pulmonology suite.